Pulished Date August, 2019
ID: 57
Share on
Share on

Europe Therapeutic Vaccines Market Research Report – Segmented By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) And By Country (France, Germany, Italy, Spain and UK) - Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 57
Pages: 141

Europe Therapeutic Vaccines Market Size and Growth (2019-2024):

Europe Therapeutic Vaccines Market Size is estimated at 704.85 Million USD in 2019 and is poised to reach 2767.34 Million USD by 2024 with a CAGR of 31.46% during the forecast period 2019-2024.

Therapeutic vaccines help to treat diseases by strengthening immunity. Currently, in the pipeline, several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years.

The therapeutic vaccine Market differs from any other commodity market because compared to its relatively small size, it appears to be doing well. It is because the vaccine market is rather concentrated on both the supply and demand sides. Though it is highly regulated in the Europe region and mostly dependent on public purchasers and donor policies, it seems to be thriving due to the recent onset of many epidemics and well availability of resources in this particular region. Increase in funding’s from the government for vaccine development, rise in investments by the major market players, rising prevalence of the disease, technological advancements, initiatives by NGOs are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high costs associated with treatment are few factors inhibiting the growth of the market.

Europe Therapeutic Vaccines Market segmented and sub-segmented into the following categories:

By Disease Type: Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease

By Country: France, Germany, Italy, Spain, and UK.

Some of the Prominent Companies leading the Europe Therapeutic Vaccines Market Profiled in the Report are:

  1. GlaxoSmithKline, plc
  2. Merck and Company
  3. Bavarian Nordic
  4. CSL Limited
  5. Emergent BioSolutions Inc
  6. Novartis AG
  7. Johnson and Johnson
  8. MedImmune, LLC
  9. Pfizer, Inc
  10. Sanofi Pasteur
  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 By Disease Type                                                       

                                5.1.1 Autoimmune Disease Vaccines                                      

                                5.1.2 Cancer Vaccines                                    

                                                5.1.2.1 Multikine                             

                                                5.1.2.2 PR1 Peptide                        

                                                5.1.2.3 TroVax                  

                                                5.1.2.4 CYT004-MelQbG10                           

                                5.1.3 Neurological Disease Vaccines                                        

                                                5.1.3.1 ACC- 001                               

                                                5.1.3.2 CAD 106                

                                                5.1.3.3 Parkinson's Disease Vaccine                        

                                                5.1.3.4 Alzheimer's Disease                        

                                5.1.4 Infectious Disease Vaccines                                             

                                                5.1.4.1 Hepatitis C                           

                                                5.1.4.2 HIV/AIDS                              

                                                5.1.4.3 Other Infectious Disease                               

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 U.K                                                 

                6.3 Spain                                                             

                6.4 Germany                                                     

                6.5 Italy                                                               

                6.6 France                                                          

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GlaxoSMithKline plc.                                                              

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Merck and Company                                                              

                8.3 Bavarian Nordic                                                        

                8.4 CSL Limited                                                 

                8.5 Emergent Biosolutions Inc.                                                  

                8.6 Novartis AG                                                

                8.7 Johnson and Johnson                                                            

                8.8 MedImmune LLC                                                     

                8.9 Pfizer Inc.                                                    

                8.10 Sanofi Pasteur                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Therapeutic Vaccines Market By Region, From 2019-2024 ( USD Billion )
  2. Europe Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  3. Europe Autoimmune Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Cancer Vaccines Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Neurological Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  6. Europe Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  7. Europe Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  8. Europe Multikine Market By Region, From 2019-2024 ( USD Billion )
  9. Europe PR1 Peptide Market By Region, From 2019-2024 ( USD Billion )
  10. Europe TroVax Market By Region, From 2019-2024 ( USD Billion )
  11. Europe CYT004-MelQbG10 Market By Region, From 2019-2024 ( USD Billion )
  12. Europe Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  13. Europe ACC- 001 Market By Region, From 2019-2024 ( USD Billion )
  14. Europe CAD 106 Market By Region, From 2019-2024 ( USD Billion )
  15. Europe Parkinson's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  16. Europe Alzheimer's Vaccine Market By Region, From 2019-2024 ( USD Billion )
  17. Europe Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  18. Europe Hepatitis C Vaccines Market By Region, From 2019-2024 ( USD Billion )
  19. Europe HIV/AIDS Vaccines Market By Region, From 2019-2024 ( USD Billion )
  20. Europe Other Infectious Disease Vaccines Market By Region, From 2019-2024 ( USD Billion )
  21. U.K. Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  22. Germany Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  23. France Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  24. Italy Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  25. Spain Therapeutic Vaccines Market By Disease Type, From 2019-2024 ( USD Billion )
  26. U.K. Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  27. Germany Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  28. France Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  29. Italy Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  30. Spain Cancer Vaccines Market By Type, From 2019-2024 ( USD Billion )
  31. U.K. Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  32. Germany Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  33. France Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  34. Italy Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  35. Spain Neurological Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  36. U.K. Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  37. Germany Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  38. France Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  39. Italy Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )
  40. Spain Infectious Disease Vaccines Market By Type, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample